Theravance Biopharma
TBPH
#6135
Rank
$0.43 B
Marketcap
Cayman Islands
Country
$8.99
Share price
-1.43%
Change (1 day)
-18.35%
Change (1 year)
Categories
Theravance Biopharma (TBPH) - Net assets
Net assets on the balance sheet as of December 2023 : $0.21 B
According to Theravance Biopharma
's latest financial reports the company has $0.21 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Theravance Biopharma - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.21 B | -51.79% |
| 2022-12-31 | $0.44 B | -230.49% |
| 2021-12-31 | $-0.34 B | 11.46% |
| 2020-12-31 | $-0.31 B | 35.7% |
| 2019-12-31 | $-0.23 B | 333.89% |
| 2018-12-31 | $-51.59 M | -144.79% |
| 2017-12-31 | $0.11 B | -67.11% |
| 2016-12-31 | $0.35 B | 44.09% |
| 2015-12-31 | $0.24 B | -16.12% |
| 2014-12-31 | $0.28 B | -1801.13% |
| 2013-12-31 | $-17.04 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Corcept Therapeutics
CORT | $0.50 B | 137.90% | 🇺🇸 USA |
 Collegium Pharmaceutical
COLL | $0.19 B | -8.25% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $0.38 B | 82.11% | 🇺🇸 USA |
 Catalent CTLT | $3.68 B | 1,631.03% | 🇺🇸 USA |